Krystal Biotech (KRYS) Profit After Tax (2021 - 2025)
Historic Profit After Tax for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $79.4 million.
- Krystal Biotech's Profit After Tax rose 19199.78% to $79.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.9 million, marking a year-over-year increase of 27980.22%. This contributed to the annual value of $89.2 million for FY2024, which is 71557.81% up from last year.
- According to the latest figures from Q3 2025, Krystal Biotech's Profit After Tax is $79.4 million, which was up 19199.78% from $38.3 million recorded in Q2 2025.
- In the past 5 years, Krystal Biotech's Profit After Tax registered a high of $80.7 million during Q3 2023, and its lowest value of -$50.0 million during Q1 2022.
- For the 5-year period, Krystal Biotech's Profit After Tax averaged around $2.3 million, with its median value being -$15.6 million (2021).
- As far as peak fluctuations go, Krystal Biotech's Profit After Tax crashed by 21599.42% in 2022, and later skyrocketed by 373401.29% in 2025.
- Krystal Biotech's Profit After Tax (Quarter) stood at -$21.8 million in 2021, then crashed by 46.99% to -$32.1 million in 2022, then skyrocketed by 127.12% to $8.7 million in 2023, then soared by 423.23% to $45.5 million in 2024, then surged by 74.51% to $79.4 million in 2025.
- Its Profit After Tax was $79.4 million in Q3 2025, compared to $38.3 million in Q2 2025 and $35.7 million in Q1 2025.